Tulang, Baby Boy .
HRN: 24-45-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2024
MUPIROCIN 2%, 15G (TUBE)
01/25/2024
02/01/2024
TOPICAL
15g
TID
PSNB
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes